Skip to main content

UBS Group AG

Position in CLGN — CollPlant Biotechnologies Ltd

CIK 1610520 ZURICH, V8

Position in CLGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$360
+$310 QoQ
Shares Held
1,035
+989.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 15 holders
Holding Since
Jun 2021
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CLGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. CLGN ranks #525 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CLGN

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $360 1,035
2026-03-31 $50 95
2025-03-31 $62,110 24,074
2024-12-31 $79,948 22,208
2024-09-30 $59,316 11,947
2024-06-30 $35,495 7,142
2024-03-31 $25,573 4,780
2023-09-30 $31,692 5,690
2023-06-30 $53,431 6,548
2023-03-31 $56,188 8,004
2022-12-31 $58,784 7,040
2022-09-30 $62,328 9,166
2022-06-30 $60,112 7,514
2022-03-31 $38,473 3,429
2021-12-31 $86,151 5,266
2021-06-30 $42,632 2,010